[Features of bemithyl pharmacokinetics upon inhalation administration].
Kurpiakova AF, Geĭbo DS, Bykov VN, Nikiforov AS · 2014 · Eksperimental'naia i klinicheskaia farmakologiia; 2014
Study findings
The report compared inhaled, intragastric and intravenous pharmacokinetics and identified metabolites. The authors favored inhalation on pharmacokinetic grounds; the abstract does not identify the study population or establish clinical safety.
- Population and setting
- Not established from the available abstract or citation
- Evidence type
- Not classified
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Experimental or incompletely specified settings do not establish human efficacy, dosing or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Kurpiakova AF, Geĭbo DS, Bykov VN, Nikiforov AS. [Features of bemithyl pharmacokinetics upon inhalation administration]. Eksperimental'naia i klinicheskaia farmakologiia; 2014 2014.
Molekul research summary: https://molekul.io/research/bemitil-extra-25076756. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry